WHO website on the EWG
NEWS: The EWG secretariat has released a draft evaluation framework, evaluation criteria and the inventory of financing proposals. The EWG is accepting public comments through the Second Web-based Public Hearing. Deadline: September 5 2009. KEI has offered critical comments on the criteria.
The WHO Expert Working Group on R&D Financing (EWG) was established in November 2008 for mandate contained in Resolution WHA 61.21 on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property.
The EWG has a one-year mandate to examine current financing and coordination of research and development, as well as proposals for new and innovative sources of funding to stimulate research and development related to Type II and Type III diseases and the specific R&D needs of developing countries in relation to Type I diseases.
The members of the group are 24 internationally recognized policy makers and technical experts that participate in their personal capacity. Bio’s experts.
Highlight of activities to date:
- November 2008: EWG Established
- January 2009: First EWG meeting in Geneva
- March/ April 2009: First Web-based public Hearing
- June 2009: Civil society Letter to the Members of the EWG
- June 2009: Second EWG meeting in Geneva
- August/September 2009: Second Web-based public Hearing
- November 2009: possible Third EWG meeting in Geneva
- May 2010: Final report due to the 63rd WHA
MSF Submission / HAI Submission/ UNITAID Submission
Member States Submissions
Other Stakeholders Submissions
Bangladesh, Barbados, Bolivia and Suriname Submissions
On April 2009 the governments of Bangladesh, Barbados, Bolivia and Suriname (B&B&B&S) presented 5 proposals to the EWG First Web-based public Hearing:
Bangladesh, Barbados, Bolivia, and Suriname Proposal 1: Chagas Disease Prize Fund for the Development of New Treatments, Diagnostics and Vaccines
Bangladesh, Barbados, Bolivia, and Suriname Proposal 2 : A Prize Fund to Support Innovation and Access for Donor Supported Markets: Linking Rewards for Innovation to the Competitive Supply of Products for HIV-AIDS, TB, Malaria and Other Diseases for Humanitarian Uses.
Bangladesh, Barbados, Bolivia, and Suriname Proposal 3 : Proposal for WHO Discussions on a Biomedical R&D Treaty.
Bangladesh, Barbados, Bolivia, and Suriname Proposal 4 : Prize Fund for Development of Low-Cost Rapid Diagnostic Test for Tuberculosis.
Bangladesh, Bolivia, and Suriname Proposal. Prizes as a Reward Mechanism for New Cancer Treatments and Vaccines in Developing Countries.